Literature DB >> 35583820

Quantitative and qualitative liver CT: imaging feature association with histopathologically confirmed hepatic cirrhosis.

Julian G Rubino1, Amir Reza Nasirzadeh2, Christian B van der Pol3, Kiret Dhindsa4, Andrew D Chung5.   

Abstract

PURPOSE: To assess the diagnostic performance of quantitative and qualitative imaging features of hepatic cirrhosis on CT.
METHODS: A single-center retrospective cohort study was performed on all patients who had undergone non-targeted liver biopsy < 3 months following abdominal CT imaging between 2007 and 2020. Histopathology was required as a reference standard for hepatic cirrhosis diagnosis. Two readers independently assessed all CT quantitative and qualitative features, blinded to the clinical history and the reference standard. The diagnostic performance of each imaging feature was assessed using multivariate regression and logistic regression in a recursive feature elimination framework.
RESULTS: 98 consecutive patients met inclusion criteria including 26 with histopathologically confirmed hepatic cirrhosis, and 72 without cirrhosis. Liver surface nodularity (p < 0.0001), lobar redistribution (p < 0.0001), and expanded gallbladder fossa (p < 0.0016) were qualitative CT features associated with liver cirrhosis consistent between both reviewers. Liver surface nodularity demonstrated highest sensitivity (73-77%) and specificity (79-82%). Falciform space width was the only quantitative feature associated with cirrhosis, for a single reviewer (p < 0.04). Using a recursive feature elimination framework, liver surface nodularity and falciform space width were the strongest performing features for identifying cirrhosis. No feature combinations strengthened diagnostic performance.
CONCLUSION: Many quantitative and qualitative CT imaging signs of hepatic cirrhosis have either poor accuracy or poor inter-observer agreement. Qualitative imaging features of hepatic cirrhosis on CT performed better than quantitative metrics, with liver surface nodularity the most optimal feature for diagnosing hepatic cirrhosis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cirrhosis; Computed tomography; Liver; Qualitative evaluation; Quantitative evaluation

Mesh:

Year:  2022        PMID: 35583820     DOI: 10.1007/s00261-022-03550-0

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  22 in total

Review 1.  Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review.

Authors:  Federico Ravaioli; Antonio Colecchia; Luigina Vanessa Alemanni; Amanda Vestito; Elton Dajti; Giovanni Marasco; Mariarosaria Sessa; Andrea Pession; Francesca Bonifazi; Davide Festi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2019-03-21       Impact factor: 3.869

2.  Deaths: Leading Causes for 2017.

Authors:  Melonie Heron
Journal:  Natl Vital Stat Rep       Date:  2019-06

Review 3.  Liver cirrhosis.

Authors:  Emmanuel A Tsochatzis; Jaime Bosch; Andrew K Burroughs
Journal:  Lancet       Date:  2014-01-28       Impact factor: 79.321

4.  Interobserver Variability in Scoring Liver Biopsies with a Diagnosis of Alcoholic Hepatitis.

Authors:  Bela Horvath; Daniela Allende; Hao Xie; John Guirguis; Jennifer Jeung; James Lapinski; Deepa Patil; Arthur J McCullough; Srinivasan Dasarathy; Xiuli Liu
Journal:  Alcohol Clin Exp Res       Date:  2017-07-28       Impact factor: 3.455

5.  Premature mortality projections in the USA through 2030: a modelling study.

Authors:  Ana F Best; Emily A Haozous; Amy Berrington de Gonzalez; Pavel Chernyavskiy; Neal D Freedman; Patricia Hartge; David Thomas; Philip S Rosenberg; Meredith S Shiels
Journal:  Lancet Public Health       Date:  2018-07-21

Review 6.  Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Scott Friedman; John Iredale; Massimo Pinzani
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

7.  Plugged-percutaneous liver biopsy in patients with impaired coagulation and ascites.

Authors:  Pieter W Kamphuisen; Tjeerd G Wiersma; Chris J J Mulder; Richard A de Vries
Journal:  Pathophysiol Haemost Thromb       Date:  2002 Jul-Aug

8.  Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies.

Authors:  Robert P Myers; Andrew Fong; Abdel Aziz M Shaheen
Journal:  Liver Int       Date:  2008-05       Impact factor: 5.828

9.  Liver biopsy: complications in 1000 inpatients and outpatients.

Authors:  J Perrault; D B McGill; B J Ott; W F Taylor
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

10.  Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

Authors:  Raj Vuppalanchi; Aynur Unalp; Mark L Van Natta; Oscar W Cummings; Kumar E Sandrasegaran; Tariq Hameed; James Tonascia; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12-25       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.